Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters.

Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters. Abstract Text:

Tomohiko Adachi,Yoshitsugu Tajima,Tamotsu Kuroki,Takehiro Mishima,Amane Kitasato,Noritsugu Tsuneoka,Takashi Kanematsu,

The present study was designed to determine whether etodolac, a selective cyclooxygenase-2 inhibitor, prevents chemically induced intraductal papillary carcinoma (IPC) in the main pancreatic duct of hamsters. Hamsters were subjected to cholecystoduodenostomy with dissection of the distal end of the common duct. Four weeks after surgery, the surviving hamsters received subcutaneous injections of N-nitrosobis(2-oxopropyl)amine four times at a dose of 10 mg/kg body wt, every 2 weeks. The animals were divided into three groups according to the simultaneous oral intake of a standard pelleted diet containing etodolac at 0% (group CE, n = 30), 0.01% (group ET, n = 21) and 0.04% (group ET4, n = 25), respectively. Hamsters were killed for pathological examination at 36 weeks after the operation. The incidence of induced pancreatic carcinoma was 93, 81 and 72% in groups CE, ET and ET4, respectively. The pancreatic carcinomas were histologically classified into four types, i.e. tubular, papillary, cyst adenocarcinoma and IPC. The incidence of IPC and the number of IPCs per animal were significantly lower in groups ET4 (36% and 0.48) and ET (48% and 0.62) when compared with group CE (67% and 1.30). The proliferating cell nuclear antigen labeling indices in the non-cancerous epithelial cells of the main pancreatic duct were 2.8 and 6.8% in groups ET4 and ET, respectively, and were significantly lower than that in group CE (10.8%). In conclusion, etodolac inhibited N-nitrosobis(2-oxopropyl)amine-induced IPC in hamsters. Suppression of epithelial cell proliferation of the main pancreatic duct was considered as a possible mechanism of cancer prevention in this hamster model.

Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters. Publishing Authors By Initials

T Adachi,Y Tajima,T Kuroki,T Mishima,A Kitasato,N Tsuneoka,T Kanematsu,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Carcinogenesis

VOLUME: 29

Page Numbers: 830-3

Journal Abbreviation: Carcinogenesis

ISSN: 1460-2180

DAY: 21

MONTH: 02

YEAR: 2008

Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8008055

Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters.

AFFILIATION: Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Carcinogenesis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Chemopreventive effects of a selective cyclooxygenase-2 inhibitor etodolac on chemically induced intraductal papillary carcinoma of the pancreas in hamsters Related Publications

• A jejunal wall-covering method following central pancreatectomy for prevention of a pancreatic fistula: a novel technique.
• Bladder wall grafting in rats using salt-modified and collagen-coated polycaprolactone scaffolds: preliminary report.
• Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters.
• Coherent oscillations in ultrafast fluorescence of photoactive yellow protein.
• Compressive stenosis of the inferior vena cava due to localized ascites after living-donor liver transplantation.
• Congenital occurrence of solitary infantile myofibromatosis of the spleen.
• Cross-presentation of NY-ESO-1 cytotoxic T lymphocyte epitope fused to human heat shock cognate protein 70 by dendritic cells.
• De novo autoimmune hepatitis after living donor liver transplantation is unlikely to be related to immunoglobulin subtype 4-related immune disease.
• Evolution of living donor liver transplantation over 10 years: Experience of a single center.
• Experience of gastric cancer in a patient who had received a living-donor liver transplantation.
• Giant cystic meconium peritonitis associated with a cloacal anomaly: case report.
• Glycine reduces hepatic warm ischaemia-reperfusion injury by suppressing inflammatory reactions in rats.
• How should we evaluate CT during arterial portography in patients with cirrhosis?
• Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation.
• Inflammatory cytokines promote inducible nitric oxide synthase-mediated DNA damage in hamster gallbladder epithelial cells.
• Intentional conversion from tacrolimus to cyclosporine for HCV-positive patients on preemptive interferon therapy after living donor liver transplantation.
• Obturator hernia in an ageing society.
• Preliminary Study for Automated Recognition of Anatomical Structure from Torso CT images.
• Prognostic impact of marginal adipose tissue invasion in ductal carcinoma of the breast.
• Protective effects of a hibernation-inducer on hepatocyte injury induced by hypothermic preservation.
• Quality control of CT system for treatment planning using the polybinary calibration method.
• Resectable carcinoma developing in the remnant pancreas 3 years after pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreas.
• Significance of the serum level of soluble E-cadherin in patients with HCC.
• Single breath-hold multiarterial dynamic MRI of the liver at 3T using a 3D fat-suppressed keyhole technique.
• Situs ambiguous with gastric cancer: report of a case.
• Spectrum of MRI appearances of untreated metastases of the liver.
• Stable transfection of retinoblastoma gene promotes contact inhibition of cell growth and hepatocyte nuclear factor-1-mediated transcription in human hepatoma cells.
• The search for cancer stem cells in hepatocellular carcinoma.
• Transient vibronic structure in ultrafast fluorescence spectra of photoactive yellow protein.
• Two-step biliary external stent removal after living donor liver transplantation.